What's Going With SELLAS Life Sciences Stock On Wednesday?

SELLAS Life Sciences Group Inc. (NASDAQ:SLS) has surged over 200% over the last six months, with a year-to-date stock jump of around 45%.The cancer drug developer Sellas Life Sciences could be a candidate for a short squeeze, with a short interest sitting as high as 27.21%, according to Benzinga Pro data.Over the last three months, SELLAS Life Sciences’ stock has gained after the ASH 2025 data presentation and an update from the ongoing Phase 3 REGAL trial.ASH 2025 Data PresentationIn December 2025, SELLAS ...